Is Warby Parker Inc (WRBY) overvalued? · rev $771.3M
Warby Parker Inc (WRBY) is a medical instruments & supplies company listed on US.
This page asks whether Warby Parker Inc (WRBY) looks expensive on cached numbers — not a short thesis.
Latest reported WRBY revenue for 2024-12-31 was $771.3M. Net income was -$20.4M. Revenue was up 15.2% from 2023-12-31 to 2024-12-31. WRBY currently screens at market cap $2.70B.
WRBY currently screens at market cap $2.70B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next WRBY 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the WRBY stock page for the full model, not this heading.
Not investment advice.